Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Ebiomedicine|November 7, 2022
Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaquesNatalia Makarova, Tyana Singletary, M Melissa Peet, et al.British Journal of Pharmacology|September 27, 2014
Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in ratsRyan A Gregg, Michael H Baumann, John S Partilla, et al.The Journal of Infectious Diseases|December 22, 2023
Extended Postexposure Protection Against Vaginal Simian/Human Immunodeficiency Virus Infection With Tenofovir Alafenamide Fumarate/Elvitegravir Inserts in MacaquesNatalia Makarova, Tyana Singletary, M Melissa Peet, et al.Antimicrobial Agents and Chemotherapy|December 25, 2019
A Subcutaneous Implant of Tenofovir Alafenamide Fumarate Causes Local Inflammation and Tissue Necrosis in Rabbits and MacaquesJonathan T Su, Solange M Simpson, Samuel Sung, et al.Ebiomedicine|November 24, 2022
Single dose topical inserts containing tenofovir alafenamide fumarate and elvitegravir provide pre- and post-exposure protection against vaginal SHIV infection in macaquesCharles W Dobard, M Melissa Peet, Kenji Nishiura, et al.Plos One|October 10, 2022
Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 studyAndrea R Thurman, Vivian Brache, Leila Cochon, et al.Nature Communications|September 26, 2018
Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivoNina Derby, Manjari Lal, Meropi Aravantinou, et al.Pageof 3